Axon Therapies Incis A Private Medtech Company Based In Santa Claracaliforniafounded In 2014The Company Is Focused On Developing Innovative Treatments For Heart Failure Patientsparticularly Those With Preserved Ejection Fractionhfpef Axon Therapies Aims To Improve Outcomes For These Patients Through Pioneering Technology The Company Is Known For Its Frontline Therapy Called Splanchnic Ablation For Volume Managementsavm This Outpatient Procedure Uses The Axon Ablation Catheter To Perform Targeted Ablation Therapyaddressing The Overactive Sympathetic Nervous Systemwhich Contributes To Heart Failure Progressionthe Goal Of Savm Is To Normalize Volume Balance In The Body By Calming Sympathetic Nerve Activity Led By President And Ceo Chad Hoskinsaxon Therapies Has A Dedicated Team Committed To Enhancing The Lives Of Heart Failure Patients Worldwidethe Company Collaborates With Clinical Partners And Is Supported By Leading Financial Investorsreflecting Its Commitment To Advancing Heart Failure Treatments
